Author: Li, Shu-ren; Tang, Zi-jian; Li, Zai-han; Liu, Xuan
Title: Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV Cord-id: qkbfuayo Document date: 2020_4_13
ID: qkbfuayo
Snippet: Since December 2019, the infection of the new coronavirus (COVID-19) caused an outbreak of new coronavirus pneumonia in Wuhan, China, and caused great public concern. Both COVID-19 and SARS-CoV belong to the coronavirus family and both invade target cells through ACE2. An in-depth understanding of ACE2 and a series of physiological and physiological changes caused by the virus invading the human body may help to discover and explain the corresponding clinical phenomena and then deal with them ti
Document: Since December 2019, the infection of the new coronavirus (COVID-19) caused an outbreak of new coronavirus pneumonia in Wuhan, China, and caused great public concern. Both COVID-19 and SARS-CoV belong to the coronavirus family and both invade target cells through ACE2. An in-depth understanding of ACE2 and a series of physiological and physiological changes caused by the virus invading the human body may help to discover and explain the corresponding clinical phenomena and then deal with them timely. In addition, ACE2 is a potential therapeutic target. This article will summarize the role of ACE2 in multiple organ damage caused by COVID-19 and SARS-CoV, targeted blocking drugs against ACE2, and drugs that inhibit inflammation in order to provide the basis for subsequent related research, diagnosis and treatment, and drug development.
Search related documents:
Co phrase search for related documents- abnormal expression and acute lung injury: 1
- abnormal expression and acute lung injury ali: 1
- abnormal liver and acute ards respiratory distress syndrome: 1
- abnormal renal function and acute ards respiratory distress syndrome: 1
- accordingly treat and acute ards respiratory distress syndrome: 1
- ace activity and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- ace activity and acute lung failure: 1, 2
- ace activity and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8
- ace activity and acute lung injury ali: 1, 2
- ace enzyme and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ace enzyme and acute ards respiratory distress syndrome develop: 1
- ace enzyme and acute lung failure: 1, 2, 3, 4, 5, 6
- ace enzyme and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ace enzyme and acute lung injury ali: 1, 2, 3, 4, 5, 6, 7, 8, 9
- ace inhibit and acute ards respiratory distress syndrome: 1, 2, 3
- ace inhibit and acute lung injury: 1
- ace inhibit and acute lung injury ali: 1
- active ingredient and acute ards respiratory distress syndrome: 1
- active ingredient and acute lung injury: 1, 2
Co phrase search for related documents, hyperlinks ordered by date